The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

George J. Kontoghiorghes

Postgraduate Research Institute of Science


Environment and Medicine

3 Ammochostou St



Name/email consistency: low



  • Postgraduate Research Institute of Science, Technology, Environment and Medicine, 3 Ammochostou St, Cyprus. 2000 - 2006


  1. Iron mobilization from transferrin and non-transferrin-bound-iron by deferiprone. Implications in the treatment of thalassemia, anemia of chronic disease, cancer and other conditions. Kontoghiorghes, G.J. Hemoglobin (2006) [Pubmed]
  2. Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers. Kontoghiorghes, G.J. Hemoglobin (2006) [Pubmed]
  3. Advances in iron overload therapies. prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations. Kontoghiorghes, G.J., Eracleous, E., Economides, C., Kolnagou, A. Curr. Med. Chem. (2005) [Pubmed]
  4. Molecular factors and mechanisms affecting iron and other metal excretion or absorption in health and disease: the role of natural and synthetic chelators. Kontoghiorghes, G.J., Kolnagou, A. Curr. Med. Chem. (2005) [Pubmed]
  5. The design and development of deferiprone (L1) and other iron chelators for clinical use: targeting methods and application prospects. Kontoghiorghes, G.J., Pattichis, K., Neocleous, K., Kolnagou, A. Curr. Med. Chem. (2004) [Pubmed]
  6. Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine. Kontoghiorghes, G.J., Neocleous, K., Kolnagou, A. Drug. Saf (2003) [Pubmed]
  7. Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1). Kontoghiorghes, G.J., Pattichi, K., Hadjigavriel, M., Kolnagou, A. Transfus. Sci (2000) [Pubmed]
WikiGenes - Universities